Zinka Clear Zinc Oxide Sunscreen Lotion
NDC Package 52993-001-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Zinka Clear Zinc Oxide Sunscreen (octinoxate, zinc oxide, octisalate, oxybenzone) lotions is apply liberally 20 minutes before sun exposure to dry skinReapply to dry skin after toweling, swimming or sweatingFor children under 6 months of age: Ask a doctor. This formulation utilizes a lotion delivery system. Marketed by Zinka, Inc., this product is identified by NDC 52993-001 and is authorized under FDA application M020.

Identification & Billing

NDC Package Code
52993-001-03
Package Description
85.1 g in 1 TUBE
Product Code
52993-001
11-Digit Billing Format
52993000103

Clinical Specifications

Proprietary Name
Zinka Clear Zinc Oxide Sunscreen
Non-Proprietary Name
Octinoxate, Zinc Oxide, Octisalate, Oxybenzone
Substance Name
Octinoxate; Octisalate; Oxybenzone; Zinc Oxide
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
Apply liberally 20 minutes before sun exposure to dry skinReapply to dry skin after toweling, swimming or sweatingFor children under 6 months of age: Ask a doctor

Regulatory & Marketing

Labeler Name
Zinka, Inc.
Product Type
Human Otc Drug
FDA Application #
M020
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
03-01-2007
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52993-001-03 identifies a specific commercial package of 85.1 g in 1 tube of Zinka Clear Zinc Oxide Sunscreen, a human over the counter drug labeled by Zinka, Inc.. This lotion is formulated for topical use and contains octinoxate; octisalate; oxybenzone; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zinka, Inc. on March 01, 2007. The current certification is valid through December 31, 2026.

How is this Zinka, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52993000103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52993-001-03
11-Digit CMS (5-4-2)
52993-0001-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.